RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30146% above fair value

$1.16−0.06 (-4.92%)

Close on Nov 12, 2026Market cap $52.35MP/E –Yield –

RenovoRx total assets

Total assets on the balance sheet at the end of each period.

RenovoRx's total assets was $12.44M at Sep 30, 2026. For fiscal 2025 it was $8.10M, down 0.3% from the year before. The highest annual figure on record is $16.29M in fiscal 2021.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$8.10M	-0.3%
FY2024	Dec 31, 2024	$8.12M	+453.8%
FY2023	Dec 31, 2023	$1.47M	-79.8%
FY2022	Dec 31, 2022	$7.27M	-55.4%
FY2021	Dec 31, 2021	$16.29M	+750.9%
FY2020	Dec 31, 2020	$1.91M	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$12.44M	+11.0%
Q2 FY2026	Jun 30, 2026	$11.47M	-15.9%
Q1 FY2026	Mar 31, 2026	$13.96M	-12.8%
Q4 FY2025	Dec 31, 2025	$8.10M	-0.3%
Q3 FY2025	Sep 30, 2025	$11.21M	+11.7%
Q2 FY2025	Jun 30, 2025	$13.64M	+13.7%
Q1 FY2025	Mar 31, 2025	$16.01M	+234.5%
Q4 FY2024	Dec 31, 2024	$8.12M	+453.8%
Q3 FY2024	Sep 30, 2024	$10.03M	+185.1%
Q2 FY2024	Jun 30, 2024	$12.00M	+90.1%
Q1 FY2024	Mar 31, 2024	$4.79M	+5.0%
Q4 FY2023	Dec 31, 2023	$1.47M	-79.8%
Q3 FY2023	Sep 30, 2023	$3.52M	-62.0%
Q2 FY2023	Jun 30, 2023	$6.31M	-43.8%
Q1 FY2023	Mar 31, 2023	$4.56M	-67.3%
Q4 FY2022	Dec 31, 2022	$7.27M	-55.4%
Q3 FY2022	Sep 30, 2022	$9.25M	-49.1%
Q2 FY2022	Jun 30, 2022	$11.24M	+487.4%
Q1 FY2022	Mar 31, 2022	$13.95M	–
Q4 FY2021	Dec 31, 2021	$16.29M	–
Q3 FY2021	Sep 30, 2021	$18.18M	–
Q4 FY2020	Dec 31, 2020	$1.91M	–